KR910005880A - 인플루엔자 비루스감염예방 및 치료제 - Google Patents

인플루엔자 비루스감염예방 및 치료제 Download PDF

Info

Publication number
KR910005880A
KR910005880A KR1019900005403A KR900005403A KR910005880A KR 910005880 A KR910005880 A KR 910005880A KR 1019900005403 A KR1019900005403 A KR 1019900005403A KR 900005403 A KR900005403 A KR 900005403A KR 910005880 A KR910005880 A KR 910005880A
Authority
KR
South Korea
Prior art keywords
influenza virus
virus infection
tea
theaflavin
treatment
Prior art date
Application number
KR1019900005403A
Other languages
English (en)
Other versions
KR0180001B1 (ko
Inventor
타다카쯔 시마무라
유끼히꼬 하라
Original Assignee
시마무라 라다카쓰
수무라 가즈오
미쓰이 노린 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시마무라 라다카쓰, 수무라 가즈오, 미쓰이 노린 가부시끼가이샤 filed Critical 시마무라 라다카쓰
Publication of KR910005880A publication Critical patent/KR910005880A/ko
Application granted granted Critical
Publication of KR0180001B1 publication Critical patent/KR0180001B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

인플루엔자 비루스감염예방 및 치료제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 차(tea)를 유효성분으로 함유하는 인플루엔자 비루스 감염예방 및 치료제.
  2. 제1항에 있어서, 유효성분이 차의 성분으로부터 추출된 차폴리페놀인 인플루엔자 비루스감염예방 및 치료제.
  3. 제2항에 있어서, 차폴리페놀이 에피갈로 카테린 갈레이트, 에피카테킨 갈레이트, 에피갈로카테킨, 에피라케킨, (+) 카테킨 및 그들의 이성질체, 유리형 테이플라빈, 테아플라빈 모노 칼레이트 A, 테아플라빈 모노갈레이트 B 및 테아플라빈 디갈레이트로 구성되는 군에서 선택된 인플루엔자 비루스 감염예방 및 치료제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900005403A 1989-09-14 1990-09-04 인플루엔자비루스 감염예방 및 치료제 KR0180001B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1-236950 1989-09-14
JP1236950A JP2727471B2 (ja) 1989-09-14 1989-09-14 インフルエンザウィルス感染予防剤

Publications (2)

Publication Number Publication Date
KR910005880A true KR910005880A (ko) 1991-04-27
KR0180001B1 KR0180001B1 (ko) 1999-03-20

Family

ID=17008162

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900005403A KR0180001B1 (ko) 1989-09-14 1990-09-04 인플루엔자비루스 감염예방 및 치료제

Country Status (8)

Country Link
US (1) US5137922A (ko)
EP (1) EP0417385B1 (ko)
JP (1) JP2727471B2 (ko)
KR (1) KR0180001B1 (ko)
AT (1) ATE108660T1 (ko)
AU (1) AU628513B2 (ko)
CA (1) CA2014555C (ko)
DE (1) DE69010807T2 (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100792626B1 (ko) * 2006-05-30 2008-01-09 프로테온 주식회사 카테킨 유도체 화합물을 유효성분으로 하는 독감 바이러스감염성 질환 예방 및 치료제
KR100853442B1 (ko) * 2007-08-21 2008-08-21 프로테온 주식회사 카테킨 유도체 화합물을 유효성분으로 하는 독감 바이러스감염성 질환 예방용 건강식품

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3018013B2 (ja) * 1989-10-19 2000-03-13 三井農林株式会社 α―アミラーゼ活性阻害剤
JP3005012B2 (ja) * 1990-02-23 2000-01-31 三井農林株式会社 抗生物質耐性ブドウ球菌感染予防剤
JP2719088B2 (ja) * 1993-03-29 1998-02-25 松下精工株式会社 抗ウィルスフィルタおよびウィルス除去装置および熱交素子および加湿機
JP3333584B2 (ja) * 1993-04-19 2002-10-15 三井農林株式会社 歯質の耐酸性強化組成物
GB9321558D0 (en) * 1993-10-19 1993-12-08 Radopath Ltd Anti-viral agents
US5670154A (en) * 1994-01-10 1997-09-23 Mitsui Norin Co., Ltd. Reducing tyrosinase activity
GB2294878A (en) * 1994-11-14 1996-05-15 Joan Louise Hibberd Antiviral tea compositions
JP2718653B2 (ja) * 1995-01-31 1998-02-25 日本配合飼料株式会社 新規卵および卵質改良方法
GB2300578B (en) * 1995-05-11 1998-01-14 Matsushita Seiko Kk Gargling cup,antiviral mask,antiviral filter,antifungal,antibacterial,and antiviral filter air cleaner and air-cleaner-humidifier
US5888527A (en) * 1995-05-11 1999-03-30 Matsushita Seiko Co., Ltd. Gargling cup, antiviral mask, antiviral filter, antifungal, antibacterial, and antiviral filter air cleaner and air-cleaner humidifier
US6197808B1 (en) 1996-11-18 2001-03-06 Cancer Instititute (Hospital), Chinese Academy Of Medical Sciences Methods for treating hyperplasia
US5968973A (en) * 1996-11-18 1999-10-19 Cancer Institute (Hospital), Chinese Academy Of Medical Sciences Method for treating hyperplasia
JP3213557B2 (ja) * 1996-11-18 2001-10-02 三井農林株式会社 茶カテキンを有効成分として含有する尖圭コンジローマ治療剤
US5776462A (en) * 1996-12-10 1998-07-07 Sage R&D, A Partnership Pogostemon cablin extract for inhibiting H. influenzae adhesion and treating otitis media or sore throat
JP3202938B2 (ja) * 1997-03-18 2001-08-27 三井農林株式会社 チューインガム及びその製造法
DE60031921T2 (de) * 1999-08-16 2007-09-20 Dsm Ip Assets B.V. Verfahren zu Herstellung von Epigallocatechin Gallate
KR100824075B1 (ko) 2000-07-28 2008-04-22 이뮤파름 에이피에스 일반 감기, 알레르기성 비염 및 호흡기에 관련된 감염 증상의 치료 방법
US7396546B2 (en) * 2001-08-06 2008-07-08 The Quigley Corporation Anti-microbial compositions and methods of using same
CA2466720C (en) * 2001-11-19 2010-02-09 Medigene Aktiengesellschaft Medicament for the treatment of viral skin and tumour diseases
DE10300222A1 (de) * 2003-01-03 2004-07-15 MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen
US20050079235A1 (en) * 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
RU2366447C2 (ru) * 2003-10-09 2009-09-10 Медигене Аг Лекарственное средство для лечения предраковых поражений кожи
US20050148658A1 (en) * 2004-01-05 2005-07-07 Charles Hensley Method for preventing and treating severe acute respiratory syndrome
WO2005089780A1 (ja) * 2004-03-18 2005-09-29 Umeda Jimusho Ltd. 抗エイズウイルス性組成物及びウイルス感染細胞の選択的不活化方法
JP5171614B2 (ja) * 2006-03-01 2013-03-27 サッポロビール株式会社 抗ウイルス剤
US20070212426A1 (en) * 2006-03-10 2007-09-13 Matthias Rath Composition and method of retarding viral activity and reducing viral replication
WO2007106884A2 (en) 2006-03-15 2007-09-20 Theralogics, Inc. Methods of treating muscular wasting diseases using nf-kb activation inhibitors
US20080075795A1 (en) 2006-09-20 2008-03-27 Charles Hensley Method and composition for preventing and treating avian influenza in poultry
US8465782B2 (en) * 2006-09-21 2013-06-18 Immune Guard, LLC Methods and materials for reducing risk of cold and/or flu
US20080119545A1 (en) * 2006-09-21 2008-05-22 Charles Hensley Method for preventing and treating avian influenza in human
JP5126942B2 (ja) * 2006-12-26 2013-01-23 静岡県公立大学法人 ５，７−ジデオキシエピガロカテキンガレート、その製法及び抗インフルエンザウイルス剤
JP5579449B2 (ja) * 2008-02-01 2014-08-27 株式会社プロテクティア 膜融合阻害剤
FR2937538B1 (fr) * 2008-10-23 2010-12-31 Muselier Corinne Treger Produit antigrippal
WO2011013825A1 (ja) 2009-07-31 2011-02-03 国立大学法人大阪大学 抗菌剤
JP5653034B2 (ja) * 2009-12-18 2015-01-14 株式会社 伊藤園 抗ウイルス剤
JP5673560B2 (ja) * 2010-01-29 2015-02-18 パナセア ディシンフェクタント カンパニー リミテッド 持続性口腔用殺菌消毒液
JP5838969B2 (ja) * 2010-02-26 2016-01-06 味の素株式会社 低分子化合物とアルギニンとを含有するウイルス不活化用組成物
CN103257116A (zh) * 2013-03-29 2013-08-21 江汉大学 一种测定茶多酚棕榈酸酯含量的方法
CN103421051B (zh) * 2013-08-02 2016-01-20 浙江大学 吸附法分离制备茶多酚的方法
CN104189262A (zh) * 2014-09-10 2014-12-10 江苏吟春碧芽股份有限公司 溶剂法萃取茶多酚的新工艺
KR20160079473A (ko) * 2014-12-26 2016-07-06 (주)피치켐 녹차 추출물을 유효성분으로 포함하여 항바이러스 활성을 가지는 세정 또는 소독용 조성물 제조방법
CN112402328B (zh) * 2020-12-30 2023-06-27 福建臻昕美生物科技有限公司 一种淡化细纹补水提亮的茶多酚亮颜精华油及其生产工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5312897A (en) * 1976-07-23 1978-02-04 Nourinshiyou Chiyagiyou Shiken Production of theaflauin and derivative thereof
JPS5695182A (en) * 1980-12-18 1981-08-01 Norin Suisansyo Chiyagiyou Shikenjo Production of catechin
JPS59196884A (ja) * 1983-04-20 1984-11-08 Nippon Shinyaku Co Ltd 新規なるタンニン
JPS59219384A (ja) * 1983-05-30 1984-12-10 Mitsui Norin Kk 天然抗酸化剤の製造方法
JPS6013780A (ja) * 1983-07-05 1985-01-24 Mitsui Norin Kk 茶カテキン類の製造方法
JPS61238728A (ja) * 1985-04-16 1986-10-24 Mitsui Norin Kk 茶葉抽出物と活性水酸化アルミニウムとの抗潰瘍性複合体
JPS62142181A (ja) * 1986-12-08 1987-06-25 Nippon Shinyaku Co Ltd 新規なるタンニン
JPS63214183A (ja) * 1987-03-03 1988-09-06 Mitsui Norin Kk アンジオテンシン１変換酵素阻害剤
US5159069A (en) * 1988-12-20 1992-10-27 Yamanouchi Pharmaceutical Co., Ltd. Sulfated tannins and their salts
JP3018013B2 (ja) * 1989-10-19 2000-03-13 三井農林株式会社 α―アミラーゼ活性阻害剤

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100792626B1 (ko) * 2006-05-30 2008-01-09 프로테온 주식회사 카테킨 유도체 화합물을 유효성분으로 하는 독감 바이러스감염성 질환 예방 및 치료제
KR100853442B1 (ko) * 2007-08-21 2008-08-21 프로테온 주식회사 카테킨 유도체 화합물을 유효성분으로 하는 독감 바이러스감염성 질환 예방용 건강식품

Also Published As

Publication number Publication date
JPH03101623A (ja) 1991-04-26
EP0417385A3 (en) 1991-04-24
CA2014555C (en) 1999-12-14
EP0417385A2 (en) 1991-03-20
DE69010807T2 (de) 1994-10-27
US5137922A (en) 1992-08-11
CA2014555A1 (en) 1991-03-14
KR0180001B1 (ko) 1999-03-20
AU628513B2 (en) 1992-09-17
JP2727471B2 (ja) 1998-03-11
EP0417385B1 (en) 1994-07-20
DE69010807D1 (de) 1994-08-25
ATE108660T1 (de) 1994-08-15
AU5319490A (en) 1991-03-21

Similar Documents

Publication Publication Date Title
KR910005880A (ko) 인플루엔자 비루스감염예방 및 치료제
KR910007538A (ko) α-아밀라아제 활성저해제
ATE117891T1 (de) Zahnbelag verhindernde mittel.
DE69732402D1 (de) Zusammensetzung zur Behandlung von Kondyloma acuminata
BR0302672A (pt) Formulação farmacêutica nutriente compreendendo polifenóis e seus usos no tratamento de câncer
CO4410203A1 (es) Formulaciones de analogos de insulina
KR910015293A (ko) 항생물질 내성 포도상 구균 감염예방제
ES2071227T3 (es) Composicion para gotas para los ojos.
EP0819433A3 (en) Compositions for increasing the efficacy of cancer drugs with tea catechin and/or theaflavin
ES2150727T3 (es) Microbicidas.
KR930001925A (ko) 수크라제 활성저해방법
KR910000130A (ko) 진경제
IE46171L (en) N-pyrrolidinylmethylbenzamide derivative.
DE69724490D1 (de) Substanz zur Behandlung der Alopezie
SE8902124L (sv) Anvaendning av pentandiol eller hexandiol foer framstaellning av ett medel foer behandling av infektioner orsakade av herpesvirus
KR940001884A (ko) 혈당 상승 억제 방법
JPS53133249A (en) Non-toxic stabilized composition of olefinic high polymer
KR940003550A (ko) 노인성 치매 예방 및 치료방법
JPS5283942A (en) Medicine for superficial infection through skin
WO1999065511A3 (en) Composition and method for treatment of pseudomonas infection
KR970005306A (ko) 항-HIV 제제로서의 IFN-ω
KR960021043A (ko) 스코폴레틴을 포함하는 b형 간염 치료제
JPS53141223A (en) Preparation of aromatic polyamine
KR930005620A (ko) 백내장 치료용 조성물
IT8863285V0 (it) Dispositivo di protezione contro le punture accidentali da aghi di siringhe o simili.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121011

Year of fee payment: 15

EXPY Expiration of term